Rituximab: converging mechanisms of action in non-Hodgkin's lymphoma?
- PMID: 14676100
Rituximab: converging mechanisms of action in non-Hodgkin's lymphoma?
Comment on
-
Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5866-73. Clin Cancer Res. 2003. PMID: 14676108
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources